Special Issue Title:

Prognosis and Treatment of Breast Cancer

Deadline for manuscript submissions: 30 June 2022

Print Special Issue Flyer (2)

Special Issue Editor

  • Guest Editor

    Akshara Singareeka Raghavendra, MDE-MailWebsite

    Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Interests: Pathways to overcome hormone therapy resistance; Prognostic factors; Use of multimodality imaging techniques for early detection and treatment of breast cancer

Special Issue Information

Dear Colleagues,

Prognostic and Predictive factors influencing breast cancer: It is now well established that women with early stage disease may have micro metastases, thus putting them at risk of developing overt metastases. This has been the main justification for using adjuvant systemic therapy in early stage breast cancer patients. However, many patients receive this therapy with little benefit and substantial toxicity, while others who do not receive adjuvant therapy still do well and show no evidence of recurrence or metastases. This highlights the need to optimize the use of adjuvant therapy based on individual prognostic and predictive factors. Prognostic factors provide information on clinical outcome at the time of diagnosis, independent of any therapy.

New efforts are being made in the area of breast cancer prognosis and detection. Broadening this effort to predict the likelihood of tumor spread to a specific location may improve our current approach to the treatment or surveillance of metastasis/recurrence and to its early detection.

The scope of this issue is to cover recent perspectives on breast cancer prognosis and the predictive factors involved, with an emphasis on finding robust and contemporary prognostic models for overall survival in early stage and metastatic breast cancer patients.

Treatment strategies for early and advanced stages of breast cancer: Improved screening techniques have led to increased diagnosis of early stage breast cancers, including stages I-III. Patients with early stage breast cancer generally have a good prognosis, but there is still a risk of disease recurrence and breast cancer-related death.

The scope of this issue includes the evaluation of treatment patterns and outcomes in patients with hormone receptor positive, HER2 negative, triple negative biomarkers in early stage breast cancer, locally advanced breast cancer, and metastatic breast cancer. This issue will also describe current treatment patterns and their effectiveness, unusual responders to treatment, and the evaluation of genomic alterations and their correlation with patient outcomes. We aim to assess different neoadjuvant and metastatic chemotherapy regimens and their effectiveness in terms of impact on overall or progression-free survival.

Dr. Akshara Singareeka Raghavendra

Guest Editor


Staging;Chemotherapy;Metastasis;Biomarker;Overall survival;Progression-free survival

Manuscript Submission Information

Manuscripts should be submitted online by submit system. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Original articles, case reports or comprehensive reviews are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website. Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. European Journal of Gynaecological Oncology is an international peer-reviewed open access journal published by MRE Press. Please visit the Instructions for Authors page before submitting a manuscript.The Article Processing Charge (APC) for publication in this open access journal is $1200. We normally offer a discount greater than 30% to all contributors invited by the Editor-in-Chief, Guest Editor (GE) and Editorial board member. Submitted papers should be well formatted and use good English.

Share This Special Issue

Published Papers (1 papers)

Open Access Special Issue

Association of anemia and neutrophil-lymphocyte ratio with overall survival in breast cancer patients

Rafael de Carvalho da Silva,Raphael Elias Ferreira,Tatiana Castrillon Guaresqui,Lúcia Marina Scatena,Beatriz Martins Tavares-Murta,Eddie Fernando Candido Murta,Rosekeila Simões Nomelini

DOI: 10.22514/ejgo.2022.014

(This article belongs to the Special Issue Prognosis and Treatment of Breast Cancer)

Abstract ( 1081 ) PDF (512.03 kB) ( 171 )

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time